We invest in
Purpose that Performs

Omicelo invests in businesses that increase access to healthcare, housing, wealth creation, and a thriving environment – delivering value profitably and at scale.

Portfolio Companies

Oakwell

Oakwell® is a real estate and infrastructure firm providing capital, engineering, and project delivery services to healthcare and higher education institutions. Oakwell unlocks significant savings that expand access to patient care and drive student success. The company was formed in partnership with Boston Medical Center Health System.

Learn More

Havenside

Havenside exists to improve the appearance, comfort, safety and long-term value of your home – your biggest asset. Havenside performs renovations, remodels, safety and accessibility improvements and handyman services for homeowners and their families.

Learn More

Vision + Values

By 2035, Omicelo will empower our portfolio companies and strategic relationships to directly impact the lives of five million people.

Trust is Our Currency

We are committed to our responsibilities and to conducting ourselves with sincere integrity – doing what we say we are going to do when we say we are going to do it. This commitment to integrity anchors the trust that we foster between teammates internally as well as with our clients and partners. This trust is the currency that our firm will draw on to sustain and grow.

Listening is Our Strategic Advantage

We listen first and fashion our solutions around what our customers need – this is how we best meet our mission. Our purposeful listening approach applies to our customers as well as our teams: by opening our ears we multiply our problem-solving capabilities – each person learns from the diverse life and professional experiences that make up our team thereby preserving time and capital.

Strong Partnerships are Our Winning Strategy

Our success depends on mutually beneficial partnerships within our team, with our partners, and with our customers. We create an atmosphere where teamwork is celebrated and doing “it” on your own is only for special situations. Finally, we ensure that our incentives are aligned with our partners and customers in a way that helps us meet our mission.

Our Innovation Multiplies Our Impact

We employ a differentiated decision-making approach that weighs three factors equally: mission alignment, scalability, and economic viability. To do this well, we expend significant energy creating the quickest path for accurate information to flow throughout our company. Making the best, information-rich decisions at the optimum time grows our ability to meet our mission exponentially.

Investment Approach

Mission Alignment
Omicelo employs a ‘missional radar’ to identify and collaborate with scalable, mission-aligned stakeholders
Comprehensive Due Diligence
Omicelo is committed to evidence-based decision-making, using intensive data and research to scale returns.
Financial Innovation
Omicelo attracts private market investors, fund managers, corporations, health systems, and government agencies to realize competitive financial returns while advancing our mission.
Transparent Accountability
Omicelo is forthright in our investment processes, financial reporting, and initiative outcomes submitting to the highest level of accountability to all stakeholders.

Leadership

Joshua Pollard

Managing Partner, CEO

Joshua is the founder and CEO of Omicelo, a private investment group making strategic investments that directly increase access to quality healthcare, viable housing, wealth creation opportunities, and a thriving environment. Prior to founding Omicelo, Joshua led Goldman Sachs’ housing research team through the Great Recession and was a critical member of their universal research team covering real estate, alternative energy, and other global sectors. During his time at Goldman Sachs, Joshua led the research efforts of a $1 billion IPO and received numerous awards including being named to Forbes Magazine’s inaugural 30 under 30 list.

Kathleen Feeney

Managing Partner, COO

Kathy brings over 30 years of deep operational expertise to Omicelo as its Chief Operating Officer. With direct leadership experience spanning multiple industries, Omicelo and its portfolio companies benefit from Kathy’s decorated capability to scale businesses and navigate corporate challenges. Prior to joining the firm, Kathy led multiple financial services firms and managed an acquisitive legal consortium that grew from 3 law firms to 10 law firms and from 4 states to 26 states geographically. Kathy also spearheaded technology and policy efforts for Freddie Mac as an operational team member and subsequently as a board member of Freddie Mac’s National Advisory Group for At Risk Loans.

Jeffrey Wilde

Managing Partner, CFO

Jeffrey leads the integrated finance and data science efforts of Omicelo, a combination that sets Omicelo’s investment capabilities apart from other investment groups. Prior to joining the firm, Jeffrey was a Vice President at The Carlyle Group and the lead portfolio manager for two real estate funds in excess of $2 billion. He built proprietary economic predictive models using advanced statistical coding programs and acquired a unique combination of business skills to help companies scale alongside the finance acumen to lead accounting and reporting teams. Jeffrey also served as a Repo Trader at GMAC RFC Securities and a Quantitative Analyst for Corporate Executive Board before it was acquired by Gartner Inc.

We want to get to know you

Let’s talk about how we can work together to bring real, life-changing improvements to your business.

team@omicelo.com

+1 (412) 376-4000

171 Industry Dr, Pittsburgh, PA 15275

We invest in Purpose that Performs